Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.52 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21437958 | 0.85 | MTNR1A (0.51) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL7373176 | 0.83 | CYP3A4 (0.48) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL31587683 | 0.83 | CA12 (0.39) | POLBMTNR1AMTNR1BCA1 | |
| SCHEMBL7368806 | 0.82 | POLB (0.79) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL7373180 | 0.81 | POLB (0.44) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL8413349 | 0.81 | PRKCI (0.44) | POLBHSD17B10 | |
| SCHEMBL6036442 | 0.81 | POLB (0.56) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL7453167 | 0.80 | POLB (0.40) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL7453174 | 0.80 | POLB (0.40) | POLBMTNR1AMTNR1BNPC1RAB9A | |
| SCHEMBL7453171 | 0.80 | POLB (0.43) | POLBMTNR1AMTNR1BHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1000031-A4 | VITRONECTIN RECEPTOR ANTAGONIST | SMITHKLINE BEECHAM CORP (US) | 2001-08-16 | — | — | EP | disclosed |
| US-6239138-B1 | TREATMENT OF INFLAMMATION, CANCER, CARDIOVASCULAR DISORDERS, SUCH AS ATHEROSCLEROSIS AND RESTENOSIS, OSTEOPOROSIS, BENZOCYCLOHEPTENYL IN WHICH A NITROGEN-CONTAINING SUBSTITUENT IS PRESENT ON THE AROMATIC SIX-MEMBERED RING AND AN ALIPHATIC | SMITHKLINE BEECHAM CORPORATION | 2001-05-29 | — | — | US | disclosed |
| EP-1000031-A1 | VITRONECTIN RECEPTOR ANTAGONIST | SmithKline Beecham Corporation (US) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999005107-A1 | VITRONECTIN RECEPTOR ANTAGONIST | SMITHKLINE BEECHAM CORPORATION (US) | 1999-02-04 | — | — | WO | disclosed |